BR100 Decreased By (-0.24%)
BR30 Decreased By (-0.28%)
KSE100 Decreased By (-0.15%)
KSE30 Decreased By (-0.16%)
AGHA 6.42 Increased By ▲ 0.10 (1.58%)
BECO 4.29 Increased By ▲ 0.02 (0.47%)
BML 62.45 No Change ▼ 0.00 (0%)
BOP 31.37 Increased By ▲ 0.14 (0.45%)
CNERGY 11.72 Increased By ▲ 0.13 (1.12%)
CSIL 5.97 Increased By ▲ 0.25 (4.37%)
FCCL 60.70 Decreased By ▼ -0.84 (-1.36%)
FFL 14.91 Decreased By ▼ -0.11 (-0.73%)
FNEL 1.25 Increased By ▲ 0.02 (1.63%)
KEL 6.25 Decreased By ▼ -0.01 (-0.16%)
KOSM 5.62 Increased By ▲ 0.06 (1.08%)
LOTCHEM 24.65 Decreased By ▼ -0.03 (-0.12%)
MLCF 102.90 Decreased By ▼ -1.18 (-1.13%)
NBP 174.63 Decreased By ▼ -0.65 (-0.37%)
NCPL 52.83 Increased By ▲ 0.06 (0.11%)
NPL 54.55 Increased By ▲ 0.43 (0.79%)
OGDC 312.50 Decreased By ▼ -0.89 (-0.28%)
PACE 9.22 Increased By ▲ 0.02 (0.22%)
PAEL 35.45 Decreased By ▼ -0.35 (-0.98%)
PIBTL 13.57 Increased By ▲ 0.10 (0.74%)
PPL 220.70 Decreased By ▼ -1.11 (-0.5%)
PRL 80.31 Increased By ▲ 1.23 (1.56%)
PTC 46.98 Increased By ▲ 0.13 (0.28%)
SSGC 24.12 Increased By ▲ 0.25 (1.05%)
TBL 9.20 Decreased By ▼ -0.11 (-1.18%)
TELE 7.40 Increased By ▲ 0.01 (0.14%)
TPL 24.40 Decreased By ▼ -0.71 (-2.83%)
TPLP 12.48 Decreased By ▼ -0.03 (-0.24%)
TREET 25.94 Decreased By ▼ -0.31 (-1.18%)
TRG 53.65 Increased By ▲ 0.21 (0.39%)
World

AstraZeneca denounces 'me first' approach to Covid jabs

  • "Globally, it is fair to say we could and should have been better prepared for this pandemic," he added.
Published Updated
By

LONDON: The boss of British drugs giant AstraZeneca, which with Oxford University has produced a Covid vaccine, denounced Monday a "me first" approach by some countries to obtaining doses.

AstraZeneca chief executive Pascal Soriot, speaking at a virtual event for the Davos World Economic Forum, also attacked a lack of global preparation for the deadly coronavirus pandemic.

The arrival of ground-breaking Covid-19 vaccines could have been grounds for celebrating, "but it unfortunately wasn't because there was a little bit of 'me first' behaviour", Soriot said.

"Globally, it is fair to say we could and should have been better prepared for this pandemic," he added.

Soriot noted however that "things are changing and international collaboration is emerging" over the coronavirus that has claimed the lives of more than two million people.

"There are many good examples of tremendous public-private collaboration actually in many countries," he said.

Going forward, "the first thing to do is to invest in prevention and early detection and early treatment", Soriot added.

He noted that among the world's most industrialised countries, only three-percent of health expenditure is spent on prevention.

"Twenty percent of this 3.0 percent... is spent on immunisation and early detections of disease.

"So, essentially, we kind of tend to wait for people to become sick to try to address that, as opposed to early detecting (of) disease and preventing it."

Comments

Comments are closed for this article.